Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P. Mar 2, 2026 05:12PM
Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P. Mar 2, 2026 05:12PM
Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P. Dec 12, 2025 05:20PM
Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P. Dec 12, 2025 05:09PM
Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P. Dec 11, 2025 05:14PM


Dec 11, 2025 05:01PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Dec 10, 2025 06:40PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Dec 10, 2025 06:31PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Feb 19, 2025 09:16AM NAYA Biosciences (NAYA) nominates new Board members
Feb 19, 2025 09:15AM NAYA Biosciences Announces Nomination of New Board Members
Nov 14, 2024 04:32PM Form SC 13G/A Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Jul 9, 2024 04:19PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Jul 9, 2024 04:17PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Jun 13, 2024 05:15PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Jun 13, 2024 05:14PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Jun 12, 2024 05:25PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Jun 12, 2024 05:24PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Mar 15, 2024 04:34PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Mar 15, 2024 04:33PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Mar 14, 2024 05:03PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Mar 14, 2024 05:02PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Mar 13, 2024 07:54PM Form 4 Kymera Therapeutics, For: Mar 11 Filed by: Atlas Venture Associates Opportunity I, L.P.
Mar 13, 2024 04:56PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Mar 13, 2024 04:56PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Mar 12, 2024 05:18PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Mar 12, 2024 05:03PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Mar 11, 2024 05:05PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Mar 11, 2024 05:02PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Feb 9, 2024 04:04PM Form SC 13G/A Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Feb 14, 2023 04:32PM Form SC 13G/A Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Jan 13, 2023 04:51PM Form 4 Kymera Therapeutics, For: Jan 11 Filed by: Atlas Venture Associates Opportunity I, L.P.
Dec 16, 2022 05:04PM Form 4 Kymera Therapeutics, For: Dec 14 Filed by: Atlas Venture Associates Opportunity I, L.P.
Nov 4, 2022 04:32PM Form 4 Kymera Therapeutics, For: Nov 02 Filed by: Atlas Venture Associates Opportunity I, L.P.
Nov 1, 2022 07:35PM Form 4 Kymera Therapeutics, For: Oct 28 Filed by: Atlas Venture Associates Opportunity I, L.P.
Aug 11, 2022 10:01AM ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox
Feb 11, 2022 05:28PM Form SC 13G/A Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Aug 12, 2021 10:42AM Form 4 Kymera Therapeutics, For: Aug 11 Filed by: Atlas Venture Associates X, LLC
May 18, 2021 06:17PM Form 4 Kymera Therapeutics, For: May 18 Filed by: Atlas Venture Fund X, L.P.
Mar 16, 2021 07:38PM Form 4 Kymera Therapeutics, For: Mar 12 Filed by: Atlas Venture Associates X, LLC
Feb 22, 2021 04:59PM Form 4 Kymera Therapeutics, For: Feb 18 Filed by: Atlas Venture Fund X, L.P.
Feb 16, 2021 05:32PM Form SC 13G Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Aug 25, 2020 04:31PM Form 4 Kymera Therapeutics, For: Aug 25 Filed by: Atlas Venture Associates Opportunity I, LLC
Aug 20, 2020 08:40PM Form 3 Kymera Therapeutics, For: Aug 20 Filed by: Atlas Venture Fund X, L.P.